Select Medical Earnings Reports

Select Medical Holdings Corporation reported a 7.8% increase in revenue for Q4 2024, reaching $1.31 billion. However, the company posted a net loss from continuing operations of $10.5 million due to a one-time stock compensation acceleration of $45.9 million and a $17.9 million loss on early retirement of debt. Adjusted EPS increased by 50% to $0.18. Adjusted EBITDA rose 3.8% to $116.0 million.

Select Medical Holdings Corporation reported a 5.7% increase in revenue, reaching $1,761.2 million for the third quarter ended September 30, 2024. Net income increased by 33.2% to $81.0 million, and earnings per common share increased by 13.2% to $0.43.

Select Medical Holdings Corporation reported a 5.1% increase in revenue to $1,759.7 million for the second quarter ended June 30, 2024, compared to $1,674.5 million for the same quarter, prior year. Net income increased 3.2% to $94.8 million, and earnings per share were $0.60.

Select Medical Holdings Corporation reported a 7.4% increase in revenue to $1,788.8 million for the first quarter ended March 31, 2024, compared to $1,665.0 million for the same quarter, prior year. Net income increased 37.4% to $117.2 million, and earnings per share increased 33.9% to $0.75.

Select Medical Holdings Corporation reported a 4.9% increase in revenue to $1,658.9 million for the fourth quarter ended December 31, 2023. Net income increased 63.9% to $61.8 million, and earnings per common share increased 63.6% to $0.36.

Select Medical Holdings Corporation reported a 6.2% increase in revenue to $1,665.7 million for the third quarter ended September 30, 2023, compared to $1,567.8 million for the same quarter, prior year. Net income increased 59.5% to $60.8 million. Earnings per common share increased 75.8% to $0.38, and adjusted earnings per common share increased 113.7% to $0.46.

Select Medical Holdings Corporation reported a 5.7% increase in revenue to $1,674.5 million for the second quarter ended June 30, 2023, compared to $1,584.7 million for the same quarter, prior year. Net income increased 38.6% to $91.9 million, and earnings per share increased 44.0% to $0.61.

Select Medical Holdings Corporation reported a 4.1% increase in revenue to $1,665.0 million for the first quarter ended March 31, 2023, compared to $1,599.5 million for the same quarter prior year. Net income increased 52.4% to $85.3 million, compared to $55.9 million for the same quarter, prior year.

Select Medical Holdings Corporation reported a revenue increase of 1.4% to $1,581.5 million for the fourth quarter ended December 31, 2022. However, net income decreased to $37.7 million compared to $66.3 million for the same quarter prior year. Earnings per common share was $0.22 for the fourth quarter ended December 31, 2022, compared to $0.37 for the same quarter, prior year.

Select Medical Holdings Corporation reported a revenue increase of 2.2% to $1,567.8 million for the third quarter ended September 30, 2022. However, net income decreased to $38.1 million, and earnings per common share was $0.21, compared to $100.2 million and $0.57, respectively, for the same quarter last year.

Select Medical Holdings Corporation reported a 1.3% increase in revenue to $1,584.7 million for the second quarter ended June 30, 2022, compared to $1,564.0 million for the same quarter, prior year. Net income was $66.3 million, compared to $196.2 million for the same quarter, prior year. Earnings per common share was $0.43, compared to $1.22 for the same quarter, prior year.

Select Medical Holdings Corporation announced its first quarter results for the period ended March 31, 2022. Revenue increased by 3.4% to $1,599.5 million, while net income decreased to $55.9 million, and income from operations decreased to $104.0 million.

Select Medical Holdings Corporation reported a 6.8% increase in revenue to $1,559.8 million for the fourth quarter ended December 31, 2021, compared to $1,460.5 million for the same quarter the prior year. Net income was $66.3 million, compared to $102.2 million for the same quarter the prior year. Earnings per common share was $0.37, compared to $0.57 for the same quarter the prior year.

Select Medical Holdings Corporation reported a 7.8% increase in revenue to $1,534.2 million for the third quarter ended September 30, 2021, compared to $1,423.9 million for the same quarter, prior year. Net income was $100.2 million, compared to $104.5 million for the same quarter, prior year.

Select Medical Holdings Corporation announced strong second-quarter results with a 26.9% increase in revenue to $1,564.0 million and a 190.7% increase in net income to $196.2 million compared to the same quarter last year. Earnings per share increased to $1.22, and adjusted EBITDA rose by 91.3% to $342.0 million.

Select Medical Holdings Corporation reported a revenue increase of 9.3% to $1,546.5 million, with net income rising by 94.8% to $137.2 million and earnings per share increasing to $0.82 for the first quarter ended March 31, 2021.

Select Medical Holdings Corporation reported a revenue increase of 6.2% to $1,460.5 million for the fourth quarter ended December 31, 2020. Net income increased by 134.1% to $102.2 million, and earnings per share increased to $0.57 on a fully diluted basis.

Select Medical Holdings Corporation reported a 2.2% increase in net operating revenues to $1,423.9 million for the third quarter ended September 30, 2020. Net income increased by 137.2% to $104.5 million, and earnings per common share was $0.57 on a fully diluted basis.

Select Medical reported net operating revenues of $1,232.7 million for the second quarter ended June 30, 2020, compared to $1,361.4 million for the same quarter, prior year. Net income increased 12.5% to $67.5 million, and earnings per common share was $0.39 on a fully diluted basis.

Select Medical Holdings Corporation reported a strong first quarter for 2020, with a 6.8% increase in net operating revenues to $1,414.6 million and a 32.1% increase in net income to $70.4 million. Earnings per share increased to $0.40, and adjusted earnings per share was $0.37.

Select Medical Holdings Corporation announced its Q4 2019 results, with net operating revenues increasing by 8.7% to $1,374.6 million, income from operations increasing by 27.3% to $112.4 million, and net income increasing by 46.9% to $43.7 million compared to the same quarter of the prior year. Adjusted EBITDA increased by 16.9% to $171.9 million, and adjusted earnings per common share was $0.31 on a fully diluted basis.